GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a prominent focus in medical investigation, largely due to its impressive impact on treating ailments such as adult-onset diabetes and weight gain. New trials have revealed that more than glucose control, GLP-1 medications offer promise for cardiovascular well-being and